Terapie antiremodeling: Nuove strategie e prospettive future nell'insufficienza cardiaca cronica post ischemica: Parte I

Translated title of the contribution: Anti remodeling therapy: New strategies and future perspective in post-ischemic heart failure: Part I

Domenico Sirico, Andrea Salzano, Dario Celentani, Michele Arcopinto, Alberto Maria Marra, Emanuele Bobbio, Angelo Russo, Francesco Giallauria, Carlo Vigorito

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regulate the response of cardiac tissue to ischemic injury. These involve various cell types such as fibroblasts, cells of the immune system, endothelial cells, cardiomyocytes and stem cells, as well as a myriad of mediators belonging to the system of cytokines and not only. In parallel with the latest findings on post-infarct remodeling, new potential therapeutic targets are arising to halt the progression of disease. In this review, we evaluate the results obtained from four new therapeutic strategies: in this part we evaluate gene therapy and novel aspect of stem cells therapy in remodeling; in the second part we will investigate, micro-RNA, posttranslational modification and microspheres based therapy.

Original languageItalian
Pages (from-to)187-194
Number of pages8
JournalMonaldi Archives for Chest Disease - Cardiac Series
Volume82
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Heart Failure
Stem Cells
Post Translational Protein Processing
Cell- and Tissue-Based Therapy
MicroRNAs
Microspheres
Cardiac Myocytes
Genetic Therapy
Disease Progression
Immune System
Therapeutics
Endothelial Cells
Fibroblasts
Myocardial Infarction
Cytokines
Incidence
Wounds and Injuries

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Terapie antiremodeling : Nuove strategie e prospettive future nell'insufficienza cardiaca cronica post ischemica: Parte I. / Sirico, Domenico; Salzano, Andrea; Celentani, Dario; Arcopinto, Michele; Marra, Alberto Maria; Bobbio, Emanuele; Russo, Angelo; Giallauria, Francesco; Vigorito, Carlo.

In: Monaldi Archives for Chest Disease - Cardiac Series, Vol. 82, No. 4, 2014, p. 187-194.

Research output: Contribution to journalArticle

Sirico, D, Salzano, A, Celentani, D, Arcopinto, M, Marra, AM, Bobbio, E, Russo, A, Giallauria, F & Vigorito, C 2014, 'Terapie antiremodeling: Nuove strategie e prospettive future nell'insufficienza cardiaca cronica post ischemica: Parte I', Monaldi Archives for Chest Disease - Cardiac Series, vol. 82, no. 4, pp. 187-194. https://doi.org/10.4081/monaldi.2014.63
Sirico, Domenico ; Salzano, Andrea ; Celentani, Dario ; Arcopinto, Michele ; Marra, Alberto Maria ; Bobbio, Emanuele ; Russo, Angelo ; Giallauria, Francesco ; Vigorito, Carlo. / Terapie antiremodeling : Nuove strategie e prospettive future nell'insufficienza cardiaca cronica post ischemica: Parte I. In: Monaldi Archives for Chest Disease - Cardiac Series. 2014 ; Vol. 82, No. 4. pp. 187-194.
@article{e18a7385279c465ba257f735c61429b7,
title = "Terapie antiremodeling: Nuove strategie e prospettive future nell'insufficienza cardiaca cronica post ischemica: Parte I",
abstract = "In recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regulate the response of cardiac tissue to ischemic injury. These involve various cell types such as fibroblasts, cells of the immune system, endothelial cells, cardiomyocytes and stem cells, as well as a myriad of mediators belonging to the system of cytokines and not only. In parallel with the latest findings on post-infarct remodeling, new potential therapeutic targets are arising to halt the progression of disease. In this review, we evaluate the results obtained from four new therapeutic strategies: in this part we evaluate gene therapy and novel aspect of stem cells therapy in remodeling; in the second part we will investigate, micro-RNA, posttranslational modification and microspheres based therapy.",
keywords = "Cardiac remodeling, Gene therapy, Heart failure, Micro-RNA, Microspheres, Post-translational modification, Stem cells",
author = "Domenico Sirico and Andrea Salzano and Dario Celentani and Michele Arcopinto and Marra, {Alberto Maria} and Emanuele Bobbio and Angelo Russo and Francesco Giallauria and Carlo Vigorito",
year = "2014",
doi = "10.4081/monaldi.2014.63",
language = "Italian",
volume = "82",
pages = "187--194",
journal = "Monaldi Archives for Chest Disease",
issn = "1122-0643",
publisher = "Fondazione Salvatore Maugeri",
number = "4",

}

TY - JOUR

T1 - Terapie antiremodeling

T2 - Nuove strategie e prospettive future nell'insufficienza cardiaca cronica post ischemica: Parte I

AU - Sirico, Domenico

AU - Salzano, Andrea

AU - Celentani, Dario

AU - Arcopinto, Michele

AU - Marra, Alberto Maria

AU - Bobbio, Emanuele

AU - Russo, Angelo

AU - Giallauria, Francesco

AU - Vigorito, Carlo

PY - 2014

Y1 - 2014

N2 - In recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regulate the response of cardiac tissue to ischemic injury. These involve various cell types such as fibroblasts, cells of the immune system, endothelial cells, cardiomyocytes and stem cells, as well as a myriad of mediators belonging to the system of cytokines and not only. In parallel with the latest findings on post-infarct remodeling, new potential therapeutic targets are arising to halt the progression of disease. In this review, we evaluate the results obtained from four new therapeutic strategies: in this part we evaluate gene therapy and novel aspect of stem cells therapy in remodeling; in the second part we will investigate, micro-RNA, posttranslational modification and microspheres based therapy.

AB - In recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regulate the response of cardiac tissue to ischemic injury. These involve various cell types such as fibroblasts, cells of the immune system, endothelial cells, cardiomyocytes and stem cells, as well as a myriad of mediators belonging to the system of cytokines and not only. In parallel with the latest findings on post-infarct remodeling, new potential therapeutic targets are arising to halt the progression of disease. In this review, we evaluate the results obtained from four new therapeutic strategies: in this part we evaluate gene therapy and novel aspect of stem cells therapy in remodeling; in the second part we will investigate, micro-RNA, posttranslational modification and microspheres based therapy.

KW - Cardiac remodeling

KW - Gene therapy

KW - Heart failure

KW - Micro-RNA

KW - Microspheres

KW - Post-translational modification

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84950249752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950249752&partnerID=8YFLogxK

U2 - 10.4081/monaldi.2014.63

DO - 10.4081/monaldi.2014.63

M3 - Articolo

AN - SCOPUS:84950249752

VL - 82

SP - 187

EP - 194

JO - Monaldi Archives for Chest Disease

JF - Monaldi Archives for Chest Disease

SN - 1122-0643

IS - 4

ER -